找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Challenges and Opportunities of mRNA Vaccines Against SARS-CoV-2; A Multidisciplinary Siguna Mueller Book 2023 The Editor(s) (if applicabl

[复制链接]
查看: 10795|回复: 54
发表于 2025-3-21 17:28:35 | 显示全部楼层 |阅读模式
书目名称Challenges and Opportunities of mRNA Vaccines Against SARS-CoV-2
副标题A Multidisciplinary
编辑Siguna Mueller
视频videohttp://file.papertrans.cn/224/223419/223419.mp4
概述Analyzes the the risks and benefits of mass vaccination with mRNA vaccines.Covers the most recent scientific data on Covid-19 mRNA vaccines.Offers a broad multidisciplinary look at mRNA vaccines
图书封面Titlebook: Challenges and Opportunities of mRNA Vaccines Against SARS-CoV-2; A Multidisciplinary  Siguna Mueller Book 2023 The Editor(s) (if applicabl
描述.This book offers an analytical look at the much debated risks and benefits of the newly developed COVID-19 mRNA-vaccines. As such, it is one of the first books to give a comprehensive overview of mRNA vaccines against COVID-19 and the only one that addresses this topic from a broad multidisciplinary background. It brings together insights from various underlying disciplines on the challenges of developing and evaluating the most suitable vaccines for mass vaccination programs enrolled throughout the world - focusing on safety and efficacy...This book should not be missing on the shelf of any biomedical researcher, epidemiologist, public health professional or clinical researcher interested in SARS-CoV2 or virology and vaccine development in general. .
出版日期Book 2023
关键词Vaccines; RNA Vaccines; COVID19; mRNA Vaccines; Public Health; Pharmacovigilance; SARS-CoV-2; Corona Virus;
版次1
doihttps://doi.org/10.1007/978-3-031-18903-6
isbn_softcover978-3-031-18905-0
isbn_ebook978-3-031-18903-6
copyrightThe Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerl
The information of publication is updating

书目名称Challenges and Opportunities of mRNA Vaccines Against SARS-CoV-2影响因子(影响力)




书目名称Challenges and Opportunities of mRNA Vaccines Against SARS-CoV-2影响因子(影响力)学科排名




书目名称Challenges and Opportunities of mRNA Vaccines Against SARS-CoV-2网络公开度




书目名称Challenges and Opportunities of mRNA Vaccines Against SARS-CoV-2网络公开度学科排名




书目名称Challenges and Opportunities of mRNA Vaccines Against SARS-CoV-2被引频次




书目名称Challenges and Opportunities of mRNA Vaccines Against SARS-CoV-2被引频次学科排名




书目名称Challenges and Opportunities of mRNA Vaccines Against SARS-CoV-2年度引用




书目名称Challenges and Opportunities of mRNA Vaccines Against SARS-CoV-2年度引用学科排名




书目名称Challenges and Opportunities of mRNA Vaccines Against SARS-CoV-2读者反馈




书目名称Challenges and Opportunities of mRNA Vaccines Against SARS-CoV-2读者反馈学科排名




单选投票, 共有 1 人参与投票
 

1票 100.00%

Perfect with Aesthetics

 

0票 0.00%

Better Implies Difficulty

 

0票 0.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用户组没有投票权限
发表于 2025-3-21 21:04:40 | 显示全部楼层
发表于 2025-3-22 01:25:01 | 显示全部楼层
Challenges and Opportunities of mRNA Vaccines Against SARS-CoV-2978-3-031-18903-6
发表于 2025-3-22 07:53:45 | 显示全部楼层
Siguna MuellerAnalyzes the the risks and benefits of mass vaccination with mRNA vaccines.Covers the most recent scientific data on Covid-19 mRNA vaccines.Offers a broad multidisciplinary look at mRNA vaccines
发表于 2025-3-22 08:58:31 | 显示全部楼层
发表于 2025-3-22 14:54:48 | 显示全部楼层
发表于 2025-3-22 17:53:10 | 显示全部楼层
发表于 2025-3-22 23:34:45 | 显示全部楼层
发表于 2025-3-23 01:22:55 | 显示全部楼层
Grundlagen der empirischen Untersuchung,ectiveness. Although this is a well-known problem in general, there is no easy solution. Even if one can spend 10 or 15 years assessing a new medical intervention, the problem is still difficult. People respond differently, often expose unexpected biological mechanisms triggered by the intervention,
发表于 2025-3-23 06:23:45 | 显示全部楼层
https://doi.org/10.1057/9781403919618alth (PH) officials and decision bodies keep asserting that these vaccines are safe. To those who have experienced adverse events (AEs), or who have close friends or family members who got injured or even passed post-vaccination, this seems incomprehensible. After all, it should be easy to prove tha
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 吾爱论文网 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
QQ|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-8-25 20:49
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表